Command Palette

Search for a command to run...

Jenburkt Pharmaceuticals Ltd.
1061(-2.05%)
1W: -1.71%

Jenburkt Pharmaceuticals Quarterly Results

Pros & Cons

POSITIVES
    No data available
NEGATIVES
  • No revenue data available, making it hard to assess performance trends.
  • Absence of profit figures limits insights into profitability and efficiency.
  • Lack of historical context leaves gaps in understanding financial trajectory.

Quarterly Results Data (Numbers are in Crore)

FieldTrendSep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25
Revenue
38.2935.6638.8432.5441.2236.8941.0535.53
Expenses
29.1928.4728.9923.2529.7928.0730.1926.57
Operating Profit
9.107.199.859.2911.438.8210.868.96
Other Income
1.101.351.191.411.851.581.882.06
Interest
0.070.070.060.110.120.110.110.11
Depreciation
0.590.630.620.520.640.780.790.72
Profit Before Tax
9.547.8410.3710.0612.529.5111.8310.18
Tax
2.222.442.482.652.923.013.302.39
Net Profit
7.325.407.887.429.606.518.547.79
Eps in Rs
16.5912.2517.8616.8021.7514.7519.3417.66

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.